PCN6- MODELLING THE COST-EFFECTIVENESS OF DOCETAXEL IN THE SECOND LINE TREATMENT OF NON-SMALL-CELL LUNG CANCER (NSCLC)
Sep 1, 2001, 00:00
10.1016/S1098-3015(11)71566-2
https://www.valueinhealthjournal.com/article/S1098-3015(11)71566-2/fulltext
Title :
PCN6- MODELLING THE COST-EFFECTIVENESS OF DOCETAXEL IN THE SECOND LINE TREATMENT OF NON-SMALL-CELL LUNG CANCER (NSCLC)
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(11)71566-2&doi=10.1016/S1098-3015(11)71566-2
First page :
Section Title :
Open access? :
No
Section Order :
80